Takeda Pharmaceutical (TAK) Change in Cash (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Change in Cash of -$881.0 million for Q2 2026, down 290.2% year-over-year from $463.2 million in Q2 2025, and down 126.57% quarter-over-quarter from -$388.9 million in Q1 2026.
Takeda Pharmaceutical (TAK) Change in Cash (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Change in Cash history runs 9 years deep, the most recent figure standing at -$881.0 million for Q2 2026.
- In Q2 2026, Change in Cash fell 290.2% year-over-year to -$881.0 million; the TTM figure through Jun 2026 stood at $570.7 million (up 120.49% YoY), while the FY2026 annual figure was $1.2 billion, up 389.65% from the prior year.
- Change in Cash for Q2 2026 stood at -$881.0 million, down from -$388.9 million in the prior quarter.
- The five-year high for Change in Cash was $2.2 billion in Q3 2025, with the low at -$2.6 billion in Q4 2024.
- The 5-year median for Change in Cash is -$272.1 million (2025), against an average of -$144.2 million.
- Peak annual rise in Change in Cash reached 4082.0% in 2024, while the deepest fall reached 1318.61% in 2024.
- Takeda Pharmaceutical's Change in Cash stood at -$732.0 million in 2022, then soared by 75.44% to -$179.8 million in 2023, then tumbled by 1318.61% to -$2.6 billion in 2024, then surged by 87.52% to -$318.4 million in 2025, then sank by 176.75% to -$881.0 million in 2026.
- Business Quant data shows TAK's Change in Cash at -$881.0 million in Q2 2026, -$388.9 million in Q1 2026, and -$318.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.31 Bn | 39.66 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.65 Bn | 29.98 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.18 Bn | 19.52 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.94 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.70 Bn | 15.31 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 159.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -881.03 Mn |
| Mar 31, 2026 | -388.85 Mn |
| Dec 31, 2025 | -318.35 Mn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | -225.79 Mn |
| Mar 31, 2025 | -650.96 Mn |
| Dec 31, 2024 | -2.55 Bn |
| Sep 30, 2024 | 642.18 Mn |
| Jun 30, 2024 | 2.12 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | -179.80 Mn |
| Sep 30, 2023 | -16.13 Mn |
| Jun 30, 2023 | -1.69 Bn |
| Mar 31, 2023 | -1.14 Bn |
| Dec 31, 2022 | -732.02 Mn |
| Sep 30, 2022 | 1.03 Bn |
| Jun 30, 2022 | -1.75 Bn |
| Mar 31, 2022 | 913.36 Mn |
| Dec 31, 2021 | 970.45 Mn |
| Sep 30, 2021 | -428.02 Mn |